Pigmerise Md 50ML
Fagron.
Coadjuvant in the treatment of hypopigmentation caused by vitiligo
Apply Pigmerise® MD each day, preferably in the evening.
Apply a thin layer of cream on the areas to be treated according to the following instructions:
- Start with the areas where the skin is thickest;
- Then apply a thin layer of cream on the more sensitive areas such as the contour of the lips, eyes or genitals.
It is advisable to rinse the treated area the day after the treatment.
Suitable for adults and children from 2 years of age.
1 application per day.
Pigmerise® MD is shown as a support of the phase of re-pigmentation of vitiligo, used in monothérapieou in combination with other treatments.
Clinical research* shows that, with daily use of Pigmerise® MD, in association with beyond therapy:
- a repigmentation of more than 50 % is obtained in 80 % of cases;
- a re-pigmentation of 76 % to 100 % is achieved in 50% of cases;
- the treatment is well tolerated, and, if it is properly used, there is no significant side effect.
Pigmerise® MD is a cream liposomal formulation, based on Piper nigrum phytocomplexe highly dosed, is innovative. The Piper nigrum phytocomplexe is a powerful blend with an antioxidant action. The liposomes provide a fast and effective absorption of active ingredients by the skin. Pigmerise® MD thus stimulates the proliferation of cells responsible for the pigmentation of the skin, the melanocytes.